Overview
Overview
Parent Cell: Equal blend of Akira MSC Exosomes Akira Neural Exosomes Akira Muscle Exosomes (110B each) | Next-generation intimate wellness exosome therapy delivering 330 billion vesicles in a trilineage formulation targeting erectile dysfunction, sexual wellness, and intimate tissue regeneration
FOR RESEARCH USE AND INTERNATIONAL USE ONLY
| Source & Manufacturing |
|---|
| 330 Billion Exosomes / 3 mL vial — composed of 110B MSC 110B Neural 110B Muscle exosomes |
| Each component fraction independently characterized and blended under sterile conditions |
| Animal-product free |
| DMSO-free |
| Stored at −80°C |
Definition
What Are Exosomes?
Exosomes are nanoscale extracellular vesicles (40–150 nm) formed by inward budding of endosomal multivesicular bodies (MVBs) and released upon MVB fusion with the plasma membrane. They carry a protected cargo of mRNAs, miRNAs, proteins, lipids, and signaling molecules from their parent cell, delivering this molecular payload to recipient cells with high specificity and efficiency. Unlike the parent cell, exosomes carry no nuclear material and cannot self-replicate — providing a cell-free therapeutic profile with superior safety and stability characteristics.
Process
Mechanism of Action & Molecular Cargo
Vascular Regeneration (MSC Exosome Component): VEGF, eNOS mRNA, and miR-126 activate endothelial NO production and angiogenesis in penile/vaginal microvasculature. NO-mediated smooth muscle relaxation enables engorgement, directly addressing vascular ED.
Neural Sensitivity Restoration (Neural Exosome Component): BDNF, GDNF, and miR-132 support peripheral nerve regeneration and sensitivity in genital tissue. Nerve fiber density improvement directly translates to enhanced sensation and arousal response.
Smooth Muscle & Tissue Firmness (Muscle Exosome Component): miR-206, IGF-1, and myogenic cargo restore corpus cavernosal smooth muscle tone, contractility, and structural integrity — key determinants of erectile rigidity and vaginal tissue turgor.
Collagen Remodeling: TGF-β modulation from MSC exosome fraction drives type I collagen synthesis in connective tissue, improving structural support and reducing Peyronie's plaque — relevant for penile tissue remodeling applications.
Anti-Fibrotic & Anti-Inflammatory: Combined anti-fibrotic miRNA cargo from all three fractions prevents profibrotic degeneration of intimate tissue — addressing Peyronie's disease, vaginal fibrosis post-radiation, and postpartum connective tissue changes.
Biomarkers
Key Molecular Cargo
| Molecule / miRNA | Therapeutic Function |
|---|---|
| VEGF / eNOS mRNA (MSC) | Endothelial NO synthesis; vasodilation and engorgement mechanism |
| miR-126 (MSC) | Endothelial integrity; VEGF signaling optimization |
| BDNF / GDNF (Neural) | Peripheral nerve regeneration; sensory improvement |
| miR-132 (Neural) | Cholinergic nerve support; parasympathetic arousal facilitation |
| IGF-1 / miR-206 (Muscle) | Smooth muscle regeneration; structural tissue support |
| Collagen I/III ratio modulators | Anti-fibrotic; Peyronie's/vaginal fibrosis treatment |
| miR-21 (all fractions) | PI3K/Akt survival pathway; tissue preservation under oxidative stress |
Applications
Therapeutic Applications
- Men: Erectile Dysfunction (vascular, neurogenic, mixed) — primary indication
- Men: Peyronie's Disease — anti-fibrotic plaque modulation
- Men: Girth Enhancement (combined with vacuum therapy protocols)
- Men: Post-prostatectomy ED — neural and vascular recovery
- Women: Sexual Dysfunction / Reduced Arousal
- Women: Vaginal Dryness / Atrophic Vaginitis (non-hormonal treatment)
- Women: Postpartum Pelvic Floor Recovery
- Women: Urinary Stress Incontinence — urethral sphincter and pelvic floor support
- Both: Post-cancer treatment sexual dysfunction (radiation, hormone therapy)
Evidence
Clinical & Preclinical Evidence
The vascular mechanism of P-Shot enhancement is supported by eNOS/NO pathway data from endothelial cell studies showing 75% improvement in blood flow in ischemic tissue models using endothelial-specific exosome preparations — directly applicable to penile microvascular insufficiency.[1]
Neural exosome BDNF/GDNF delivery data demonstrates peripheral nerve density restoration in diabetic neuropathy models — relevant to diabetic ED where peripheral autonomic denervation contributes to vascular dysfunction.
Muscle exosome miR-206/IGF-1 data from sarcopenia models confirms smooth muscle fiber maintenance and contractility support — addressing the corpus cavernosal smooth muscle loss that characterizes advanced ED.[2]
The triple-blend rationale is supported by the multifactorial pathophysiology of ED and female sexual dysfunction, where vascular, neural, and structural components all contribute. Single-modality treatments (PDE5 inhibitors alone, O-shot/PRP alone) address only one pathway; the Akira Restore product targets all three simultaneously.
Clinical practitioners using combined exosome protocols for intimate wellness report significantly improved patient satisfaction scores, faster response onset (vs PRP alone), and 6–12 month duration of effect — consistent with the multi-pathway regenerative mechanism.